292 related articles for article (PubMed ID: 29085773)
1. Neurobiological and clinical effects of fNIRS-controlled rTMS in patients with panic disorder/agoraphobia during cognitive-behavioural therapy.
Deppermann S; Vennewald N; Diemer J; Sickinger S; Haeussinger FB; Dresler T; Notzon S; Laeger I; Arolt V; Ehlis AC; Fallgatter AJ; Zwanzger P
Neuroimage Clin; 2017; 16():668-677. PubMed ID: 29085773
[TBL] [Abstract][Full Text] [Related]
2. Does rTMS alter neurocognitive functioning in patients with panic disorder/agoraphobia? An fNIRS-based investigation of prefrontal activation during a cognitive task and its modulation via sham-controlled rTMS.
Deppermann S; Vennewald N; Diemer J; Sickinger S; Haeussinger FB; Notzon S; Laeger I; Arolt V; Ehlis AC; Zwanzger P; Fallgatter AJ
Biomed Res Int; 2014; 2014():542526. PubMed ID: 24757668
[TBL] [Abstract][Full Text] [Related]
3. Functional co-activation within the prefrontal cortex supports the maintenance of behavioural performance in fear-relevant situations before an iTBS modulated virtual reality challenge in participants with spider phobia.
Deppermann S; Notzon S; Kroczek A; Rosenbaum D; Haeussinger FB; Diemer J; Domschke K; Fallgatter AJ; Ehlis AC; Zwanzger P
Behav Brain Res; 2016 Jul; 307():208-17. PubMed ID: 26996315
[TBL] [Abstract][Full Text] [Related]
4. The impact of depressive comorbidity on neural plasticity following cognitive-behavioral therapy in panic disorder with agoraphobia.
Kunas SL; Yang Y; Straube B; Kircher T; Gerlach AL; Pfleiderer B; Arolt V; Wittmann A; Stroehle A; Wittchen HU; Lueken U
J Affect Disord; 2019 Feb; 245():451-460. PubMed ID: 30428445
[TBL] [Abstract][Full Text] [Related]
5. Facing the fear--clinical and neural effects of cognitive behavioural and pharmacotherapy in panic disorder with agoraphobia.
Liebscher C; Wittmann A; Gechter J; Schlagenhauf F; Lueken U; Plag J; Straube B; Pfleiderer B; Fehm L; Gerlach AL; Kircher T; Fydrich T; Deckert J; Wittchen HU; Heinz A; Arolt V; Ströhle A
Eur Neuropsychopharmacol; 2016 Mar; 26(3):431-44. PubMed ID: 26837851
[TBL] [Abstract][Full Text] [Related]
6. Running for extinction? Aerobic exercise as an augmentation of exposure therapy in panic disorder with agoraphobia.
Bischoff S; Wieder G; Einsle F; Petzold MB; Janßen C; Mumm JLM; Wittchen HU; Fydrich T; Plag J; Ströhle A
J Psychiatr Res; 2018 Jun; 101():34-41. PubMed ID: 29539585
[TBL] [Abstract][Full Text] [Related]
7. Modulation of dorsolateral prefrontal cortex functional connectivity after intermittent theta-burst stimulation in depression: Combining findings from fNIRS and fMRI.
Struckmann W; Bodén R; Gingnell M; Fällmar D; Persson J
Neuroimage Clin; 2022; 34():103028. PubMed ID: 35537216
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
[TBL] [Abstract][Full Text] [Related]
9. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.
Pompoli A; Furukawa TA; Imai H; Tajika A; Efthimiou O; Salanti G
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011004. PubMed ID: 27071857
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.
Blumberger DM; Vila-Rodriguez F; Thorpe KE; Feffer K; Noda Y; Giacobbe P; Knyahnytska Y; Kennedy SH; Lam RW; Daskalakis ZJ; Downar J
Lancet; 2018 Apr; 391(10131):1683-1692. PubMed ID: 29726344
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the prefrontal blood oxygenation response to intermittent theta-burst stimulation in depression: A sham-controlled study with functional near-infrared spectroscopy.
Struckmann W; Persson J; Weigl W; Gingnell M; Bodén R
World J Biol Psychiatry; 2021 Apr; 22(4):247-256. PubMed ID: 32640854
[TBL] [Abstract][Full Text] [Related]
12. Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression.
Mantovani A; Aly M; Dagan Y; Allart A; Lisanby SH
J Affect Disord; 2013 Jan; 144(1-2):153-9. PubMed ID: 22858212
[TBL] [Abstract][Full Text] [Related]
13. Non-inferiority of intermittent theta burst stimulation over the left V
Kong Y; Zhou J; Zhao M; Zhang Y; Tan T; Xu Z; Hou Z; Yuan Y; Tan L; Song R; Shi Y; Feng H; Wu W; Zhao Y; Zhang Z
J Affect Disord; 2023 Dec; 343():59-70. PubMed ID: 37751801
[TBL] [Abstract][Full Text] [Related]
14. Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes.
Gottschalk MG; Richter J; Ziegler C; Schiele MA; Mann J; Geiger MJ; Schartner C; Homola GA; Alpers GW; Büchel C; Fehm L; Fydrich T; Gerlach AL; Gloster AT; Helbig-Lang S; Kalisch R; Kircher T; Lang T; Lonsdorf TB; Pané-Farré CA; Ströhle A; Weber H; Zwanzger P; Arolt V; Romanos M; Wittchen HU; Hamm A; Pauli P; Reif A; Deckert J; Neufang S; Höfler M; Domschke K
Transl Psychiatry; 2019 Feb; 9(1):75. PubMed ID: 30718541
[TBL] [Abstract][Full Text] [Related]
15. Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT.
Gloster AT; Wittchen HU; Einsle F; Lang T; Helbig-Lang S; Fydrich T; Fehm L; Hamm AO; Richter J; Alpers GW; Gerlach AL; Ströhle A; Kircher T; Deckert J; Zwanzger P; Höfler M; Arolt V
J Consult Clin Psychol; 2011 Jun; 79(3):406-20. PubMed ID: 21534651
[TBL] [Abstract][Full Text] [Related]
16. Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia.
Lueken U; Straube B; Konrad C; Wittchen HU; Ströhle A; Wittmann A; Pfleiderer B; Uhlmann C; Arolt V; Jansen A; Kircher T
Am J Psychiatry; 2013 Nov; 170(11):1345-55. PubMed ID: 23982225
[TBL] [Abstract][Full Text] [Related]
17. The effect of repetitive transcranial magnetic stimulation (rTMS) add on serotonin reuptake inhibitors in patients with panic disorder: a randomized, double blind sham controlled study.
Prasko J; Záleský R; Bares M; Horácek J; Kopecek M; Novák T; Pasková B
Neuro Endocrinol Lett; 2007 Feb; 28(1):33-8. PubMed ID: 17277734
[TBL] [Abstract][Full Text] [Related]
18. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined.
Van Apeldoorn FJ; Van Hout WJ; Timmerman ME; Mersch PP; den Boer JA
J Affect Disord; 2013 Sep; 150(2):313-9. PubMed ID: 23676529
[TBL] [Abstract][Full Text] [Related]
19. Neural correlates of the emotional Stroop task in panic disorder patients: an event-related fMRI study.
Dresler T; Hindi Attar C; Spitzer C; Löwe B; Deckert J; Büchel C; Ehlis AC; Fallgatter AJ
J Psychiatr Res; 2012 Dec; 46(12):1627-34. PubMed ID: 23058446
[TBL] [Abstract][Full Text] [Related]
20. Transdiagnostic group CBT vs. standard group CBT for depression, social anxiety disorder and agoraphobia/panic disorder: Study protocol for a pragmatic, multicenter non-inferiority randomized controlled trial.
Arnfred SM; Aharoni R; Hvenegaard M; Poulsen S; Bach B; Arendt M; Rosenberg NK; Reinholt N
BMC Psychiatry; 2017 Jan; 17(1):37. PubMed ID: 28114915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
